CDNA CareDx, Inc.companySEC Filings & Insider Trading Activity 2026
Latest CareDx, Inc. (CDNA) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 25, 2026, a 10-Q quarterly report filed on November 4, 2025, an 8-K current report filed on April 28, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for CareDx, Inc. (CDNA) (SEC CIK 1217234), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business model: Specialized molecular diagnostic testing and digital pharmacy solutions for transplant patients
- • Expanded patient and digital solutions revenue by 31%, driven by pharmacy sales growth and wider Ottr software deployment
Risk Factors
- • MolDX/Noridian Proposed LCD revision may reduce reimbursement, impose utilization limits, and introduces bundled payment, with final decision due within 365 days from July 17, 2025
- • Medicare reimbursement risk: 46% of testing revenue from Medicare, with AlloSure Kidney 2026 fee reduced by $88 to $2,753 per test after CMS crosswalk decision
Management Discussion & Analysis
- • Revenue recognition includes testing services, product sales, patient and digital solutions; testing revenue reduced by $3.5M refund reserve in 2025
- • No specific total revenue or YoY change disclosed in the MD&A section provided
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-09-30)
Risk Factors
- • New risk: Proposed MolDX draft LCD (July 17, 2025) may impose coverage criteria, utilization limits, bundled payments, risking reduced reimbursement
- • Regulatory risk: Medicare reimbursement under new CPT code 0540U subject to repricing; potential $88 rate cut for AlloSure Kidney starting Jan 2026
Annual Reports Archive10-K
AI-powered analysis of CareDx, Inc. (CDNA) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of CareDx, Inc. (CDNA) 10-Q quarterly reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of CareDx, Inc. (CDNA) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $321.8M | $280.3M | $333.8M | $379.8M |
| Operating Income | -$77.2M | -$203.4M | $40.8M | -$30.8M |
| Net Income | -$76.6M | -$190.3M | $52.5M | -$21.4M |
| Op. Margin | -24.0% | -72.5% | 12.2% | -8.1% |
| Net Margin | -23.8% | -67.9% | 15.7% | -5.6% |
| Balance Sheet | ||||
| Total Assets | $543.0M | $466.8M | $491.1M | $413.2M |
| Equity | $430.9M | $261.3M | $378.4M | $303.1M |
| ROE | -17.8% | -72.8% | 13.9% | -7.0% |
Source: XBRL financial data from CareDx, Inc. (CDNA) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 28, 2026 | — | — | — |
8-K | Apr 23, 2026 | — | — | — |
8-K | Apr 16, 2026 | — | — | — |
8-K | Feb 25, 2026 | — | Analysis | — |
10-K | Feb 25, 2026 | Dec 31, 2025 | Analysis | |
8-K | Feb 24, 2026 | — | Analysis | — |
8-K | Jan 12, 2026 | — | — | |
8-K | Dec 18, 2025 | — | — | |
8-K | Dec 15, 2025 | — | — | |
10-Q | Nov 4, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Aug 6, 2025 | Jun 30, 2025 | — | |
10-Q | Apr 30, 2025 | Mar 31, 2025 | — | |
10-K | Feb 28, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 4, 2024 | Sep 30, 2024 | — | |
10-Q | Jul 31, 2024 | Jun 30, 2024 | — | |
10-Q | May 9, 2024 | Mar 31, 2024 | — | |
10-K | Feb 28, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 8, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 8, 2023 | Jun 30, 2023 | — | |
10-Q | May 10, 2023 | Mar 31, 2023 | — | |
10-K | Feb 27, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 3, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 4, 2022 | Jun 30, 2022 | — | |
10-Q | May 5, 2022 | Mar 31, 2022 | — | |
10-K | Feb 24, 2022 | Dec 31, 2021 | — |
Frequently Asked Questions
What are the latest CDNA SEC filings in 2026?
CareDx, Inc. (CDNA) has filed a 10-K annual report on February 25, 2026, a 10-Q quarterly report on November 4, 2025, an 8-K current report on April 28, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did CDNA file its most recent 10-K annual report?
CareDx, Inc. (CDNA) filed its most recent 10-K annual report on February 25, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view CDNA 10-Q quarterly reports?
CareDx, Inc. (CDNA)'s most recent 10-Q quarterly report was filed on November 4, 2025. SignalX displays every CDNA 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has CDNA filed recently?
CareDx, Inc. (CDNA)'s most recent 8-K was filed on April 28, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find CDNA insider trading activity (Form 4)?
SignalX aggregates every CDNA Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does CDNA file with the SEC?
CareDx, Inc. (CDNA) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new CDNA filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for CareDx, Inc. (CDNA).
What is CDNA's SEC CIK number?
CareDx, Inc. (CDNA)'s SEC CIK (Central Index Key) number is 1217234. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1217234 to look up all CDNA filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find CDNA return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from CareDx, Inc. (CDNA) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of CareDx, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 44+ filings.